Eiger BioPharmaceuticals, Inc. (EIGR) Financials

EIGR Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 55.7 million 57.3 million
2023-06-30 72.4 million 57.1 million
2023-03-31 99.2 million 64.0 million
2022-12-31 120.1 million 64.8 million

EIGR Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -14.6 million 1.0 million
2023-06-30 -22.1 million 745000
2023-03-31 -24.2 million 2.5 million
2022-12-31 -22.5 million 1.8 million

EIGR Net Income

No data available :(

EIGR Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 39.4 million - 205000
2023-06-30 53.6 million 40.3 million 322000
2023-03-31 75.3 million 40.0 million 436000
2022-12-31 98.9 million 39.6 million 574000

EIGR Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 44.3 million
2023-06-30 44.3 million
2023-03-31 44.1 million
2022-12-31 44.1 million

EIGR Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 14.6 million 5.5 million -
2023-06-30 17000 19.4 million 5.5 million -
2023-03-31 216000 16.7 million 9.5 million -
2022-12-31 224000 18.5 million 8.3 million -

EIGR Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 3.2 million 115000
2023-06-30 4.6 million 310000
2023-03-31 4.1 million 118000
2022-12-31 2.7 million 345000

EIGR

Price: $1.72

52 week price:
1.10
43.35

Earnings Per Share: -58.50 USD

P/E Ratio: -0.10

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 759300

Ebitda: -8.8 million

Market Capitalization: 2.6 million

Links: